Appendix Z.2: CER Required CSv02.03 Site Specific Factors

Click to View One of the Following Tables:

 

CER Required Site Specific Factor

Breast   C50.0-C50.6, C50.8-C50.9

Site

Histology

C50.0-C50.6, C50.8-C50.9

8000-9136, 9141-9582, 9700-9701

 

Factor

CCR/SEER

CoC

CER

Description

SSF 1

X

X

X

Estrogen Receptor (ER) Assay

SSF 2

X

X

X

Progesterone Receptor (PR) Assay

SSF 3

X

X

X

Number of Positive Ipsilateral Level I-II Axillary Lymph Nodes

SSF 4

X

X

X

Immunohistochemistry (IHC) of Regional Lymph Nodes

SSF 5

X

X

X

Molecular (MOL) Studies of Regional Lymph Nodes

SSF 6

X

X

X

Size of Tumor--Invasive Component

SSF 7

X

X

X

Nottingham or Bloom-Richardson (BR) Score/Grade

SSF 8

X

X

X

HER2: Immunohistochemistry (IHC) Lab Value

SSF 9

X

X

X

HER2: Immunohistochemistry (IHC) Test Interpretation

SSF 10

X

X

X

HER2: Fluorescence In Situ Hybridization (FISH) Lab Value

SSF 11

X

X

X

HER2: Fluorescence In Situ Hybridization (FISH) Test Interpretation

SSF 12

X

X

X

HER2: Chromogenic In Situ Hybridization (CISH) Lab Value

SSF 13

X

X

X

HER2: Chromogenic In Situ Hybridization (CISH) Test Interpretation

SSF 14

X

X

X

HER2: Result of other or unknown test

SSF 15

X

X

X

HER2: Summary Result of Testing

SSF 16

 

 

X

Combinations of ER, PR, and HER2 Results

SSF 17

 

 

 

 

SSF 18

 

 

 

 

SSF 19

 

 

 

 

SSF 20

 

 

 

 

SSF 21

X

X

X

Response to Neoadjuvant Therapy

SSF 22

X

X

X

Multigene Signature Method

SSF 23

X

X

X

Multigene Signature Results

SSF 24

 

 

 

 

SSF 25

 

 

 

 

 

Back to top.

CER Required Site Specific Factor

Colon   C18.0, C18.2-C18.9

Site

Histology

C18.0, C18.2-C18.9

8000-8152, 8154-8231, 8243-8245, 8247-8248, 8250-8934, 8940-9136, 9141-9582, 9700-9701

 

Factor

CCR/SEER

CoC

CER

Description

SSF 1

X

X

X

Carcinoembryonic Antigen (CEA)

SSF 2

X

X

X

Clinical Assessment of Regional Lymph Nodes

SSF 3

X

X

X

Carcinoembryonic Antigen (CEA) Lab Value

SSF 4

X

X

X

Tumor Deposits

SSF 5

 

 

 

 

SSF 6

X

X

X

Circumferential Resection Margin (CRM)

SSF 7

 

 

X

Microsatellite Instability (MSI)

SSF 8

X

X

X

Perineural Invasion

SSF 9

X

X

X

KRAS

SSF 10

 

 

X

18q Loss of Heterozygosity (LOH)

SSF 11

 

 

 

 

SSF 12

 

 

 

 

SSF 13

 

 

 

 

SSF 14

 

 

 

 

SSF 15

 

 

 

 

SSF 16

 

 

 

 

SSF 17

 

 

 

 

SSF 18

 

 

 

 

SSF 19

 

 

 

 

SSF 20

 

 

 

 

SSF 21

 

 

 

 

SSF 22

 

 

 

 

SSF 23

 

 

 

 

SSF 24

 

 

 

 

SSF 25

 

 

 

 

 

Back to top.

CER Required Site Specific Factor

NET Colon   C18.0, C18.2-C18.9

Site

Histology

C18.0, C18.2-C18.9

8153, 8240-8242, 8246, 8249

 

Factor

CCR/SEER

CoC

CER

Description

SSF 1

 

 

 

OBSOLETE - Carcinoembryonic Antigen (CEA)

SSF 2

X

X

X

Clinical Assessment of Regional Lymph Nodes

SSF 3

 

 

 

 

SSF 4

 

 

 

 

SSF 5

 

 

 

 

SSF 6

 

 

 

 

SSF 7

 

 

 

 

SSF 8

 

 

 

 

SSF 9

 

 

 

 

SSF 10

 

 

 

 

SSF 11

 

 

 

 

SSF 12

 

 

 

 

SSF 13

 

 

 

 

SSF 14

 

 

 

 

SSF 15

 

 

 

 

SSF 16

X

X

X

Serum Chromogranin A (CgA) Lab Value

SSF 17

X

X

X

Urinary 5-Hydroxyindoleacetic Acid (5-HIAA) Lab Value

SSF 18

 

 

 

 

SSF 19

 

 

 

 

SSF 20

 

 

 

 

SSF 21

 

 

 

 

SSF 22

 

 

 

 

SSF 23

 

 

 

 

SSF 24

 

 

 

 

SSF 25

 

 

 

 

 

Back to top.

CER Required Site Specific Factor

GIST Colon   C18.0, C18.2-C18.9

Site

Histology

C18.0, C18.2-C18.9

8935-8936

 

Factor

CCR/SEER

CoC

CER

Description

SSF 1

 

 

 

OBSOLETE FOR 2010 (Pre-Operative Carcinoembryonic Antigen (CEA))

SSF 2

 

 

 

OBSOLETE FOR 2010 (Clinical Assessment of Regional Lymph Nodes)

SSF 3

 

 

 

 

SSF 4

 

 

 

 

SSF 5

 

 

 

 

SSF 6

 

 

 

 

SSF 7

 

 

 

 

SSF 8

 

 

 

 

SSF 9

 

 

 

 

SSF 10

 

 

 

 

SSF 11

X

X

X

Mitotic Count

SSF 12

X

X

X

KIT Gene Immunohistochemistry (IHC)

SSF 13

 

 

 

 

SSF 14

 

 

 

 

SSF 15

 

 

 

 

SSF 16

 

 

 

 

SSF 17

 

 

 

 

SSF 18

 

 

 

 

SSF 19

 

 

 

 

SSF 20

 

 

 

 

SSF 21

 

 

 

 

SSF 22

 

 

 

 

SSF 23

 

 

 

 

SSF 24

 

 

 

 

SSF 25

 

 

 

 

 

Back to top.

CER Required Site Specific Factor

Rectum   C19.9, C20.9

Site

Histology

C19.9, C20.9

8000-8152, 8154-8231, 8243-8245, 8247, 8248, 8250-8934, 8940-9136, 9141-9582, 9700-9701

 

Factor

CCR/SEER

CoC

CER

Description

SSF 1

X

X

X

Carcinoembryonic Antigen (CEA)

SSF 2

X

X

X

Clinical Assessment of Regional Lymph Nodes

SSF 3

X

X

X

Carcinoembryonic Antigen (CEA) Lab Value

SSF 4

X

X

X

Tumor Deposits

SSF 5

 

 

X

Tumor Regression Grade

SSF 6

X

X

X

Circumferential Resection Margin (CRM)

SSF 7

 

 

X

Microsatellite Instability (MSI)

SSF 8

X

X

X

Perineural Invasion

SSF 9

X

X

X

KRAS

SSF 10

 

 

X

18q Loss of Heterozygosity (LOH)

SSF 11

 

 

 

 

SSF 12

 

 

 

 

SSF 13

 

 

 

 

SSF 14

 

 

 

 

SSF 15

 

 

 

 

SSF 16

 

 

 

 

SSF 17

 

 

 

 

SSF 18

 

 

 

 

SSF 19

 

 

 

 

SSF 20

 

 

 

 

SSF 21

 

 

 

 

SSF 22

 

 

 

 

SSF 23

 

 

 

 

SSF 24

 

 

 

 

SSF 25

 

 

 

 

 

Back to top.

CER Required Site Specific Factor

NET Rectum   C19.9, C20.9

Site

Histology

C19.9, C20.9

8153, 8240-8242, 8246, 8249

 

Factor

CCR/SEER

CoC

CER

Description

SSF 1

 

 

 

OBSOLETE - Carcinoembryonic Antigen (CEA)

SSF 2

X

X

X

Clinical Assessment of Regional Lymph Nodes

SSF 3

       

SSF 4

       

SSF 5

       

SSF 6

       

SSF 7

       

SSF 8

       

SSF 9

       

SSF 10

       

SSF 11

       

SSF 12

       

SSF 13

       

SSF 14

       

SSF 15

       

SSF 16

X

X

X

Serum Chromogranin A (CgA) Lab Value

SSF 17

X

X

X

Urinary 5-Hydroxyindoleacetic Acid (5-HIAA) Lab Value

SSF 18

 

 

 

 

SSF 19

 

 

 

 

SSF 20

 

 

 

 

SSF 21

 

 

 

 

SSF 22

 

 

 

 

SSF 23

 

 

 

 

SSF 24

 

 

 

 

SSF 25

 

 

 

 

 

Back to top.

CER Required Site Specific Factor

GIST Rectum   C19.9, C20.9

Site

Histology

C19.9, C20.9

8935-8936

 

Factor

CCR/SEER

CoC

CER

Description

SSF 1

 

 

 

OBSOLETE FOR 2010 (Pre-Operative Carcinoembryonic Antigen (CEA))

SSF 2

 

 

 

OBSOLETE FOR 2010 (Clinical Assessment of Regional Lymph Nodes)

SSF 3

 

 

 

 

SSF 4

 

 

 

 

SSF 5

 

 

 

 

SSF 6

 

 

 

 

SSF 7

 

 

 

 

SSF 8

 

 

 

 

SSF 9

 

 

 

 

SSF 10

 

 

 

 

SSF 11

X

X

X

Mitotic Count

SSF 12

X

X

X

KIT Gene Immunohistochemistry (IHC)

SSF 13

 

 

 

 

SSF 14

 

 

 

 

SSF 15

 

 

 

 

SSF 16

 

 

 

 

SSF 17

 

 

 

 

SSF 18

 

 

 

 

SSF 19

 

 

 

 

SSF 20

 

 

 

 

SSF 21

 

 

 

 

SSF 22

 

 

 

 

SSF 23

 

 

 

 

SSF 24

 

 

 

 

SSF 25

 

 

 

 

 

Back to top.

CER Required Site Specific Factor

Appendix   C18.1

Site

Histology

C18.1

8000-8152, 8154-8231, 8243-8245, 8247-8248, 8250-8934, 8940-9136, 9141-9582, 9700-9701

 

Factor

CCR/SEER

CoC

CER

Description

SSF 1

X

X

X

Carcinoembryonic Antigen (CEA)

SSF 2

X

X

X

Clinical Assessment of Regional Lymph Nodes

SSF 3

X

X

X

Carcinoembryonic Antigen (CEA) Lab Value

SSF 4

 

 

 

 

SSF 5

 

 

 

 

SSF 6

 

 

 

 

SSF 7

 

 

X

Microsatellite Instability (MSI)

SSF 8

 

 

 

 

SSF 9

 

 

 

 

SSF 10

 

 

X

18q Loss of Heterozygosity (LOH)

SSF 11

X

X

X

Histopathological Grading

SSF 12

 

 

 

 

SSF 13

 

 

 

 

SSF 14

 

 

 

 

SSF 15

 

 

 

 

SSF 16

 

 

 

 

SSF 17

 

 

 

 

SSF 18

 

 

 

 

SSF 19

 

 

 

 

SSF 20

 

 

 

 

SSF 21

 

 

 

 

SSF 22

 

 

 

 

SSF 23

 

 

 

 

SSF 24

 

 

 

 

SSF 25

 

 

 

 

 

Back to top.

CER Required Site Specific Factor

Carcinoid / NET Appendix   C18.1

Site

Histology

C18.1

8153, 8240-8242, 8246, 8249

 

Factor

CCR/SEER

CoC

CER

Description

SSF 1

 

 

 

OBSOLETE FOR 2010 (Pre-Operative Carcinoembryonic Antigen (CEA))

SSF 2

X

X

X

Clinical Assessment of Regional Lymph Nodes

SSF 3

 

 

 

 

SSF 4

 

 

 

 

SSF 5

 

 

 

 

SSF 6

 

 

 

 

SSF 7

 

 

 

 

SSF 8

 

 

 

 

SSF 9

 

 

 

 

SSF 10

 

 

 

 

SSF 11

 

 

 

 

SSF 12

 

 

 

 

SSF 13

 

 

 

 

SSF 14

 

 

 

 

SSF 15

 

 

 

 

SSF 16

 

 

 

 

SSF 17

 

 

 

 

SSF 18

 

 

 

 

SSF 19

 

 

 

 

SSF 20

 

 

 

 

SSF 21

 

 

 

 

SSF 22

 

 

 

 

SSF 23

 

 

 

 

SSF 24

 

 

 

 

SSF 25

 

 

 

 

 

Back to top.

CER Required Site Specific Factor

GIST Appendix   C18.1

Site

Histology

C18.1

8935-8936

 

Factor

CCR/SEER

CoC

CER

Description

SSF 1

 

 

 

OBSOLETE FOR 2010 (Pre-Operative Carcinoembryonic Antigen (CEA))

SSF 2

 

 

 

OBSOLETE FOR 2010 (Clinical Assessment of Regional Lymph Nodes)

SSF 3

 

 

 

 

SSF 4

 

 

 

 

SSF 5

 

 

 

 

SSF 6

 

 

 

 

SSF 7

 

 

 

 

SSF 8

 

 

 

 

SSF 9

 

 

 

 

SSF 10

 

 

 

 

SSF 11

X

X

X

Mitotic Count

SSF 12

X

X

X

KIT Gene Immunohistochemistry (IHC)

SSF 13

 

 

 

 

SSF 14

 

 

 

 

SSF 15

 

 

 

 

SSF 16

 

 

 

 

SSF 17

 

 

 

 

SSF 18

 

 

 

 

SSF 19

 

 

 

 

SSF 20

 

 

 

 

SSF 21

 

 

 

 

SSF 22

 

 

 

 

SSF 23

 

 

 

 

SSF 24

 

 

 

 

SSF 25

 

 

 

 

 

Back to top.

CER Required Site Specific Factor

Chronic Myleogenous Leukemia (CML)  C42.1

Site

Histology

C42.1

9863, 9875, 9876, 9945, 9946

 

Factor

CCR/SEER

CoC

CER

Description

SSF 1

X

X

X

JAK-2 (also known as Janus Kinase 2 and JAK 2 Exon 12)

SSF 2

 

 

 

 

SSF 3

 

 

 

 

SSF 4

 

 

 

 

SSF 5

 

 

 

 

SSF 6

 

 

 

 

SSF 7

 

 

 

 

SSF 8

 

 

 

 

SSF 9

 

 

 

 

SSF 10

 

 

 

 

SSF 11

       

SSF 12

       

SSF 13

 

 

 

 

SSF 14

 

 

 

 

SSF 15

 

 

 

 

SSF 16

 

 

 

 

SSF 17

 

 

 

 

SSF 18

 

 

 

 

SSF 19

 

 

 

 

SSF 20

 

 

 

 

SSF 21

 

 

 

 

SSF 22

 

 

 

 

SSF 23

 

 

 

 

SSF 24

 

 

 

 

SSF 25

 

 

 

 

 

Back to top.

 

 

<< Prev.       Next >>